The TGF-β- and Smad7-induced increases of c-Jun and HDAC6 promote invasion of prostate cancer cells, making it relevant to investigate expression of Smad7, c-Jun, and HDAC6 in clinical tissue samples of patients with prostate cancer as potential biomarkers and drug targets. This evidence concerns the gene SMAD7 and prostate carcinoma.